- $237.48bn
- $280.79bn
- $36.75bn
Sling Therapeutics raises $123 million to advance thyroid eye disease drug
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
US stocks weekly: Yields bite
US stocks weekly: Yields bite
Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial (updated)
Live Markets: Back to the post-summer grind: Stocks end red
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Corrected: UPDATE 1-Amgen-AstraZeneca drug combo helps lung cancer patients live longer in late-stage study
Corrected: Amgen-AstraZeneca cancer drug combo hits main survival goal in late-stage trial
Ionis Pharma tumbles after heart drug fails late-stage trial
Amgen falls after Novartis trial setback, BMO downgrade
Amgen falls after Novartis trial setback, BMO downgrade
Novartis cholesterol setback tests hopes for emerging heart disease drugs (updated)
Novartis shares down as failed cholesterol drug study increases pipeline pressure
UK regulator suspends rare-disease drug Tavneos for new patients over unreliable data (updated)